← All stories
Markets
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
2 outlets - including Forbes and Nytimes - are covering this story. Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
Covered by 2 outlets
All coverage · 2 articles
Forbes Business
·1h ago
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
NYT Business
·2h ago
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.